Nitric Oxide Metabolite Improves Cognitive Impairment by Reducing the Loss of Parvalbumin Inhibitory Interneurons in a Novel Mouse Model of Vascular Dementia
Our results reveal a potential neuroprotective and therapeutic use of NOBM for cognitive dysfunction associated with cerebral hypoperfusion in a mouse model of VD.
Authors
- Seung‐Bum Yang (ORCID: https://orcid.org/0000-0002-4602-7626)
- Dae‐Weung Kim (ORCID: https://orcid.org/0000-0002-5289-4363)
- Min‐Sun Kim (ORCID: https://orcid.org/0000-0001-9952-0038)
- Meng Jin
- Xiaorong Zhang (ORCID: https://orcid.org/0009-0003-7840-5956)
- Lin Cheng
- Quanyu Piao
Institutions
- Jiujiang University (CN)
- Wonkwang University Hospital (KR)
- WonKwang Health Science University (KR)
- Wonkwang University (KR)
Publication Details
- Journal
- Current Neuropharmacology
- Published
- 2025-05-08
- DOI
- https://doi.org/10.2174/011570159x356939250306075324
- Citations
- 2
- Primary Topic
- Neurological Disease Mechanisms and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.68